Blood Cancer Journal Contents: 31 Jul 2022

The latest content from Blood Cancer Journal: 31 July 2022

Racial differences as predictors of outcomes in young patients with multiple myeloma Alicia Bao, Qiuhong Zhao [...] Francesca Cottini Correspondence | 27 July 2022 | Article number: 114 |  doi: 10.1038/s41408-022-00708-3

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant Federica Sora, Sabrina Giammarco [...] Emanuele Angelucci Correspondence | 26 July 2022 | Article number: 111 |  doi: 10.1038/s41408-022-00701-w

Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms Marie-France Gagnon, Shulan Tian [...] Linda B. Baughn Correspondence | 26 July 2022 | Article number: 112 |  doi: 10.1038/s41408-022-00706-5

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma Hassan B. Alkhateeb, Razan Mohty [...] Mithun Vinod Shah Correspondence | 26 July 2022 | Article number: 113 |  doi: 10.1038/s41408-022-00707-4

BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma Ellen Weisberg, Basudev Chowdhury [...] James D. Griffin Article | 19 July 2022 | Article number: 110 |  doi: 10.1038/s41408-022-00704-7

Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study Livio Pagano, Marianna Criscuolo [...] Pier Luigi Zinzani Article | 19 July 2022 | Article number: 109 |  doi: 10.1038/s41408-022-00702-9

Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma Benjamin A. Derman, Andrzej J. Jakubowiak & Michael A. Thompson Correspondence | 11 July 2022 | Article number: 108 |  doi: 10.1038/s41408-022-00705-6

A scoring system for AML patients aged 70 years or older, eligible for intensive chemotherapy: a study based on a large European data set using the DATAML, SAL, and PETHEMA registries Emilie Bérard, Christoph Röllig [...] Christian Récher Article | 11 July 2022 | Article number: 107 |  doi: 10.1038/s41408-022-00700-x

Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms Mithun Vinod Shah, Abhishek A. Mangaonkar [...] Dong Chen Article | 08 July 2022 | Article number: 106 |  doi: 10.1038/s41408-022-00703-8

G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial Tomáš Stopka, Lubomír Minařík [...] Anna Jonášová Correspondence | 07 July 2022 | Article number: 105 |  doi: 10.1038/s41408-022-00698-2

Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study Junfang Yang, Jiaping He [...] Peihua Lu Article | 07 July 2022 | Article number: 104 |  doi: 10.1038/s41408-022-00694-6

Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases Maymona G. Abdelmagid, Mark R. Litzow [...] Ayalew Tefferi Correspondence | 06 July 2022 | Article number: 103 |  doi: 10.1038/s41408-022-00696-4

Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors Theodoros P. Vassilakopoulos, Evrydiki Kravvariti [...] Gerassimos A. Pangalis Correspondence | 05 July 2022 | Article number: 102 |  doi: 10.1038/s41408-022-00674-w

Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm Axel Künstner, Julian Schwarting [...] Niklas Gebauer Correspondence | 04 July 2022 | Article number: 101 |  doi: 10.1038/s41408-022-00699-1

Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans Andrew Staron, Luke Zheng [...] Vaishali Sanchorawala Correspondence | 04 July 2022 | Article number: 100 |  doi: 10.1038/s41408-022-00697-3

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells Zhiquan Wang, Huihuang Yan [...] Neil E. Kay Article | 01 July 2022 | Article number: 99 |  doi: 10.1038/s41408-022-00690-w

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Blood Cancer Journal.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.